Tag Archives: NSCLC

Immunotherapy drug Keytruda Tops Chemo in Lung Cancer Study

FDA may offer the drug to more patients based on promising results
Posted on June 22, 2016 by Ellary Allis (Blog Writer, SevenPonds)

Researches have stopped a study of Keytruda (pembrolizumab) the immunotherapy drug that former president Jimmy Carter says helped stop the progression of his advanced melanoma, because the medication is so effective that they want to offer it to all the patients in … Continue reading →

Posted in Something Special | Tagged , , , , , , , , , , , , | 2 Comments